140 related articles for article (PubMed ID: 1390332)
21. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
Diller GP; Dimopoulos K; Kaya MG; Harries C; Uebing A; Li W; Koltsida E; Gibbs JS; Gatzoulis MA
Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112
[TBL] [Abstract][Full Text] [Related]
22. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects.
Synhorst DP; Lauer RM; Doty DB; Brody MJ
Circulation; 1976 Sep; 54(3):472-7. PubMed ID: 947577
[TBL] [Abstract][Full Text] [Related]
24. The pulmonary vascular response to oxygen and its influence on operative results in children with ventricular septal defect.
Lock JE; Einzig S; Bass JL; Moller JH
Pediatr Cardiol; 1982; 3(1):41-6. PubMed ID: 7155938
[TBL] [Abstract][Full Text] [Related]
25. Determination of the anatomical size of ventricular septal defects on the basis of hemodynamic data and noninvasive assessment of pulmonary to systemic vascular resistance ratio Rp/Rs by Doppler-echocardiography.
Rupprecht T; Hofbeck M; Singer H; Harms D; Deeg KH; Benson L
Cathet Cardiovasc Diagn; 1991 Feb; 22(2):93-9. PubMed ID: 2009570
[TBL] [Abstract][Full Text] [Related]
26. Improvement of exercise capacity after nifedipine in patients with Eisenmenger syndrome complicating ventricular septal defect.
Wong CK; Yeung DW; Lau CP; Cheng CH; Leung WH
Clin Cardiol; 1991 Dec; 14(12):957-61. PubMed ID: 1841020
[TBL] [Abstract][Full Text] [Related]
27. [Paracervical block for dilatation and curettage in a parturient with Eisenmenger's syndrome].
Tsutsumi Y; Mizuno J; Takada S; Morita S
Masui; 2010 Mar; 59(3):379-82. PubMed ID: 20229760
[TBL] [Abstract][Full Text] [Related]
28. [Hemodynamic effects of an alpha-blocking vasodilator in cardiac insufficiency caused by left-right shunt in children].
Cloez JL; Isaaz K; Marchal C; Morizot D; Pernot C
Arch Mal Coeur Vaiss; 1986 May; 79(5):677-82. PubMed ID: 3092767
[TBL] [Abstract][Full Text] [Related]
29. [Evolution and prognosis of the adult Eisenmenger syndrome].
Siegert D; Trenckmann H
Z Gesamte Inn Med; 1981 Sep; 36(17):607-11. PubMed ID: 7345807
[TBL] [Abstract][Full Text] [Related]
30. Plasma endothelin-1 in patients with left-to-right shunt.
Gorenflo M; Gross P; Bodey A; Schmitz L; Brockmeier K; Berger F; Bein G; Lange PE
Am Heart J; 1995 Sep; 130(3 Pt 1):537-42. PubMed ID: 7661072
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary vascular disease in Down's syndrome with complete atrioventricular septal defect.
Suzuki K; Yamaki S; Mimori S; Murakami Y; Mori K; Takahashi Y; Kikuchi T
Am J Cardiol; 2000 Aug; 86(4):434-7. PubMed ID: 10946038
[TBL] [Abstract][Full Text] [Related]
32. Paradoxical relationship between B-type natriuretic peptide and pulmonary vascular resistance in patients with ventricular septal defect and concomitant severe pulmonary hypertension.
Toyono M; Harada K; Tamura M; Aoki-Okazaki M; Shimada S; Oyamada J; Takada G
Pediatr Cardiol; 2008 Jan; 29(1):65-9. PubMed ID: 17786380
[TBL] [Abstract][Full Text] [Related]
33. Relationship between pulmonary arterial resistance and compliance among patients with pulmonary arterial hypertension and congenital heart disease.
Muneuchi J; Nagatomo Y; Watanabe M; Joo K; Onzuka T; Ochiai Y; Joo K
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):507-13. PubMed ID: 27189891
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic effects of ketamine in children with congenital heart disease.
Morray JP; Lynn AM; Stamm SJ; Herndon PS; Kawabori I; Stevenson JG
Anesth Analg; 1984 Oct; 63(10):895-9. PubMed ID: 6486488
[TBL] [Abstract][Full Text] [Related]
35. Congenital heart disease and pulmonary artery hypertension. I. Pulmonary vasoreactivity to 15% oxygen before and after surgery.
Waldman JD; Lamberti JJ; Mathewson JW; Kirkpatrick SE; Turner SW; George L; Pappelbaum SJ
J Am Coll Cardiol; 1983 Dec; 2(6):1158-64. PubMed ID: 6226728
[TBL] [Abstract][Full Text] [Related]
36. [Doppler sonography determination of flow ratios Qp/Qs and resistance ratios Rp/Rs in isolated ventricular septal defect].
Rupprecht T; Deeg KH; Hofbeck M; Richter K; Singer H
Ultraschall Med; 1989 Apr; 10(2):83-9. PubMed ID: 2734602
[TBL] [Abstract][Full Text] [Related]
37. [Circulatory failure in children with left-to-right shunt in the framework of congenital heart defects: pathophysiology and therapeutic results].
Wessel A; Buchhorn R; Bürsch J
Klin Padiatr; 2000; 212(2):53-9. PubMed ID: 10812553
[TBL] [Abstract][Full Text] [Related]
38. [Calculation of the pulmonary to systemic flow ratio using echo-Doppler in septal defects--correlation with oximetry].
Rufino Nascimento LG; Dehant P; Jimenez M; Dequeker JL; Castela E; Choussat A
Rev Port Cardiol; 1989 Jan; 8(1):35-40. PubMed ID: 2631813
[TBL] [Abstract][Full Text] [Related]
39. [A case of Down syndrome with ventricular septal defect and hemodynamical Eisenmenger syndrome].
Suematsu Y; Yagu K; Egami J; Yoda H; Tsuchiya K
Kyobu Geka; 2001 May; 54(5):374-8. PubMed ID: 11357299
[TBL] [Abstract][Full Text] [Related]
40. Significance of systemic vascular resistance in determining the hemodynamic effects of hydralazine on large ventricular septal defects.
Nakazawa M; Takao A; Chon Y; Shimizu T; Kanaya M; Momma K
Circulation; 1983 Aug; 68(2):420-4. PubMed ID: 6861317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
